We compared the effects of isosorbide dinitrate (ISDN) (Circulation 1990;81:1881-1886 T he mechanisms by which nitrates improve myocardial ischemia in chronic effort angina are not fully understood. Peripheral venous dilatation resulting in decreased myocardial oxygen consumption by preload reduction has been clearly established,12 but whether nitrates also increase coronary blood flow to the ischemic myocardium by relieving coronary vasoconstriction remains controversial.3-9
T he mechanisms by which nitrates improve myocardial ischemia in chronic effort angina are not fully understood. Peripheral venous dilatation resulting in decreased myocardial oxygen consumption by preload reduction has been clearly established,12 but whether nitrates also increase coronary blood flow to the ischemic myocardium by relieving coronary vasoconstriction remains controversial. [3] [4] [5] [6] [7] [8] [9] This study was designed to assess the relative contribution of peripheral and coronary vasodilatation induced by nitrates in improving exercise-induced ischemia. We approached this problem by comparing the hemodynamic effects of intracoronary and intravenous isosorbide dinitrate (ISDN) at rest and during effortinduced ischemia in a group of patients with severe coronary artery disease and very low exercise tolerance.
Methods Patients
Of 35 consecutive patients with chronic stable effort angina, we selected 10 who had a very limited coronary flow reserve. In four patients, previous myocardial infarction was documented by the patient's history and also by electrocardiographic (ECG) and angiographic criteria. We excluded patients with valvular heart disease, cardiomyopathy, unstable angina pectoris, or a history of acute myocardial infarction within the previous 6 months. All 
Protocol
Immediately after coronary angiography, patients underwent four consecutive bicycle ergometer exercise tests in the supine position ( Figure 1 ). Approximately 30 minutes for recovery was allowed between each exercise test. The first test was performed without any medication and was considered to be the control test. Two exercise levels of 3 minutes each were chosen according to the results of the preliminary treadmill test so that ischemia could be expected to develop during the first or the second exercise level. After the patients had recovered from symptoms and the ECG and hemodynamic parameters had returned to basal values, 400 ,ug ISDN (Cedocard, Isoket, Pharma Schwarz, Mannheim, FRG) were selectively infused into the ischemiarelated coronary artery. The vessel to be injected was selected according to the location of ECG changes observed during the assessment treadmill exercise and according to coronary anatomy. The most stenotic but still patent vessel was injected. The drug was infused into the left coronary artery in six patients, into the right coronary in two, and into both arteries in the remaining two (double dose). Care was taken to slowly infuse the drug during a 5-minute interval to avoid any bolus effect.
After administration of ISDN, the ECG, hemodynamic parameters, and left ventricular volumes were measured during 5 To optimize visual separation of right and left ventricles, a mobile gamma camera (model 215 M, Elscint, Haifa, Israel) was positioned over the patient's chest in the 40-50°left anterior oblique position with a 10-30°craniocaudal tilt. Nuclear data were continuously acquired in list mode before, during, and after drug administration as well as during exercise tests on a Hewlett-Packard 1000 computer (2x80 Mbyte Winchester disk, HewlettPackard, Cupertino, California).
A program developed at our institution was used for further data processing.12,13 Briefly, after QRS recognition and image reconstruction from the listmode nuclear data, a single region of interest was drawn around the left ventricle. Background radioactivity was then subtracted, and corrections were made for the decay of 99mTc during the study period.
The beat-to-beat activity curve in the left ventricular region of interest was obtained by mobile averaging for 13 beats to increase the statistics of nuclear data. during the two control exercise tests. The percent increases in left ventricular systolic and end-diastolic volumes were also similar.
The level of rate-pressure product attained after intracoronary ISDN was similar to that observed, for the same work load, during the first control exercise. However, at this level, a noticeable improvement in all ischemic end points was observed: ST segment depression was less severe (from 0.20+0.09 to 0.14+0.08, p<0.05), increase in left ventricular end-diastolic pressure was markedly reduced (from 36±7 mm to 24±8 mm, p<0.05), and increase in left ventricular volume was also markedly reduced (end-systolic volume from 91±40% to 40±29%, p<0.05; end-diastolic volume from 50±16% to 29±14%,p<0.05).
Intravenous infusion of 4 mg ISDN did not affect rate-pressure product, as the slight reduction in systolic pressure was accompanied by an increase in heart rate. For the same work load and for equivalent levels of rate-pressure product, all signs of ischemia were significantly reduced during exercise: Mean ST segment depression was 0.05±0.07 mV (range, 0-0.19 mV), and left ventricular end-diastolic pressure was 14±7 mm Hg (range, 9-32 mm Hg) ( Table 3 ).
All ischemic end points were significantly improved, both when compared with those observed during the second control exercise and with those recorded during the exercise performed after intracoronary ISDN dosing. Details of the results obtained during the four exercise tests are shown in Table 3 and in Figures 2-4 .
Discussion
Our study shows that in patients with severe coronary artery disease, the beneficial effects of nitrates in preventing or reducing exercise-induced myocardial ischemia could be at least partially mediated by coronary vasodilatation. In all patients, slow intracoronary infusion of a small dose of ISDN resulted in reduction of ECG and hemodynamic signs of acute myocardial ischemia induced by exercise.
Compared with control, ST segment depression and impairment of left ventricular function, as assessed by the increase in left ventricular enddiastolic pressures and volumes, were less severe after intracoronary administration of nitrates. The effect occurred for equivalent levels of external work load and rate-pressure product and in the absence of significant hemodynamic changes before the onset of exercise. Despite the fact that we did not measure coronary blood flow or coronary artery diameter, these findings strongly suggest that the anti-ischemic effect of ISDN was the consequence of improved perfusion of the ischemic areas by dilatation of epicardial coronary artery stenoses, by increased collateral flow, or both.
Our data are at variance with those obtained by Ganz et a15 who found that intracoronary administration of nitroglycerin had no effect in preventing or reducing pacing-induced ischemia. Two factors may contribute to the discrepancy. First, in the study performed by Ganz et al, the 75-,gg nitroglycerin bolus transiently exposed the coronary circulation to almost 200 times the pharmacologically active dose. Such a high concentration may redistribute coronary blood flow from the subendocardium to the subepicardium and from ischemic to nonischemic areas as a result of arteriolar vasodilatation and a drop in poststenotic pressure. Second, exercise but not pac- The mechanism of the improvement in myocardial perfusion is also a matter of speculation. It could result from minimal, perhaps not angiographically detectable, dilatation of critical stenoses; from dilatation of collateral vessels not visible angiographically; or from dilatation of distal coronary vessels.
In conclusion, this study indicates that exerciseinduced ischemia is relieved mainly by the peripheral effect of nitrates. However, in our patients with severe coronary artery disease and very limited exercise capacity, intracoronary nitrate infusion results in significant beneficial effects on both symptoms and signs of ischemia and suggests a direct effect on coronary blood supply.
